Supplementary Figure S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

DOI: 10.1158/1078-0432.24947902.v1 Publication Date: 2024-01-05T08:29:57Z